Delivery Order SPE2DB22D9367-SPE2DB26FSU91
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $38,633.14 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg tablets in quantities of 14 packets. The delivery order, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, operates under a firm fixed-price structure with no set-aside designation. This award represents a single transaction within...
- The Defense Logistics Agency awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete...
- The Defense Logistics Agency awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a discrete pharmaceutical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA....
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,758.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on September 29, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units, with a completion date of September 30, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a $55,450.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,316.57 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, calls for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This award was issued without a set-aside designation, allowing the vendor to compete on an open basis...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order represents a discrete purchase from DMS...
- The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a specialized pharmaceutical product delivery to support federal healthcare operations. This award carries no...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB26FSU91Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc. was selected as the awardee based on its established capability to supply pharmaceutical products to Department of Defense medical facilities. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy. The parent contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare operations globally. The vendor's selection reflects its demonstrated performance on numerous prior delivery orders and its established role as a critical pharmaceutical supplier within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 10/29/25 |